Calidi Biotherapeutics Inc. (CLDI)
Market Closed
16 Oct, 08:00 PM
AMEX AMEX Primary $
0. 84
-0.03
-3.7931%
$
2.66M Market Cap
- P/E Ratio
- Div Yield
35,091 Volume
0 Eps
$ 0.87
Previous Close Investors:
Want to track CLDI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Calidi Biotherapeutics Inc. (CLDI) Statistics
Valuation metrics
Market Cap 2.66M
Enterprise value 532.71K
Trailing P/E (ttm) -0.02
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.47
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.03
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 16.45K
Average volume (90 days) 5.89M
Price summary
52-Week low 0.09
52-Week high 1.93
Beta -
50-Day moving average 1.13
200-Day moving average 0.33
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.02
Dividend Date -
Ex-Dividend Date -
Last split factor 1:16
Last split Date 31 Jul 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.43%
Return on equity -3.73%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -12.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.88
Total debt (mrq) -
Total Debt/Equity (mrq) 0.62
Current ratio (mrq) 1.68%
Book value per share (mrq) 2.21
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
